group_id,Component_20,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_08098,1.413257783857102,FUN_035840-T1,Peve_00032502,Pocillopora_meandrina_HIv1___RNAseq.g11957.t1,three_way,76.54033333333332,FUN_035840-T1,P38532,HSF1_MOUSE,,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),Mus musculus (Mouse),55.7,176.0,1.1e-44,182.6,sp|P38532|HSF1_MOUSE Heat shock factor protein 1 OS=Mus musculus OX=10090 GN=Hsf1 PE=1 SV=2,GO:0000122; GO:0000165; GO:0000776; GO:0000791; GO:0000792; GO:0000978; GO:0001162; GO:0001227; GO:0001228; GO:0001701; GO:0001892; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006397; GO:0006952; GO:0007143; GO:0007283; GO:0007584; GO:0008283; GO:0009408; GO:0010628; GO:0010667; GO:0014823; GO:0016605; GO:0019901; GO:0031072; GO:0031333; GO:0031490; GO:0032496; GO:0032720; GO:0032991; GO:0033574; GO:0034605; GO:0034620; GO:0035865; GO:0040018; GO:0042802; GO:0043565; GO:0045120; GO:0045651; GO:0045931; GO:0045944; GO:0046982; GO:0048471; GO:0050673; GO:0050680; GO:0051028; GO:0051879; GO:0060136; GO:0061770; GO:0062029; GO:0065003; GO:0070301; GO:0071222; GO:0071276; GO:0071280; GO:0071392; GO:0071466; GO:0071480; GO:0072738; GO:0090084; GO:0090261; GO:0097165; GO:0097431; GO:0097677; GO:0098847; GO:0101031; GO:0120162; GO:0140296; GO:1900034; GO:1901652; GO:1902512; GO:1903936; GO:1904385; GO:1904843; GO:1904845; GO:1990841; GO:1990904; GO:1990910; GO:1990911; GO:2001033; GO:2001235,cell population proliferation [GO:0008283]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; epithelial cell proliferation [GO:0050673]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; response to activity [GO:0014823]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to peptide [GO:1901652]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; translation elongation factor binding [GO:0061770]",GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006355; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0065003; GO:0140013; GO:0140110,DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; organelle; anatomical structure development; protein-containing complex assembly; meiotic nuclear division; transcription regulator activity
OG_08984,1.3049374156220532,FUN_038503-T1,Peve_00041694,Pocillopora_meandrina_HIv1___RNAseq.g28159.t1,three_way,62.70366666666667,,,,,,,,,,,,,,,,,
OG_06782,1.2494130762045643,FUN_031649-T1,Peve_00043575,Pocillopora_meandrina_HIv1___TS.g24400.t2a,three_way,66.82783333333333,FUN_031649-T1,Q96PN7,TREF1_HUMAN,,Transcriptional-regulating factor 1 (Breast cancer anti-estrogen resistance 2) (Transcriptional-regulating protein 132) (Zinc finger protein rapa) (Zinc finger transcription factor TReP-132),Homo sapiens (Human),29.4,486.0,4e-39,165.6,sp|Q96PN7|TREF1_HUMAN Transcriptional-regulating factor 1 OS=Homo sapiens OX=9606 GN=TRERF1 PE=1 SV=1,GO:0000118; GO:0001223; GO:0001650; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0008270; GO:0033142; GO:0045892; GO:0045893; GO:0045944; GO:0050847; GO:0071393,cellular response to progesterone stimulus [GO:0071393]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],DNA binding [GO:0003677]; nuclear progesterone receptor binding [GO:0033142]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_06842,1.17766854641997,FUN_031782-T1,Peve_00010427,Pocillopora_meandrina_HIv1___RNAseq.g5565.t1,three_way,65.31783333333333,FUN_031782-T1,P29176,,,,,44.2,77.0,1.2e-06,55.1,sp|P29176|FOSX_MSVFR Transforming protein v-Fos/v-Fox OS=FBR murine osteosarcoma virus OX=353765 GN=FOS-FOX PE=3 SV=1,,,,,,
OG_07659,1.1771278970869996,FUN_034604-T1,Peve_00037084,Pocillopora_meandrina_HIv1___TS.g18635.t1,three_way,65.48566666666666,FUN_034604-T1,Q90XE6,KLF1_DANRE,,Kruppel-like factor 1 (Erythroid krueppel-like transcription factor) (Kruppel-like factor d),Danio rerio (Zebrafish) (Brachydanio rerio),80.0,80.0,5.7e-08,59.7,sp|Q90XE6|KLF1_DANRE Kruppel-like factor 1 OS=Danio rerio OX=7955 GN=klf1 PE=2 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005829; GO:0006357; GO:0008270; GO:0010628; GO:0010725; GO:0031100; GO:0043565; GO:0043697; GO:0045214; GO:0055007; GO:0060038; GO:0060319,animal organ regeneration [GO:0031100]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cell dedifferentiation [GO:0043697]; positive regulation of gene expression [GO:0010628]; primitive erythrocyte differentiation [GO:0060319]; regulation of primitive erythrocyte differentiation [GO:0010725]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0007010; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoskeleton organization; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_00163,1.1552703556018242,FUN_000637-T1,Peve_00012867,Pocillopora_meandrina_HIv1___RNAseq.g16016.t1,three_way,83.68833333333333,FUN_000637-T1,O97125,,,,,74.2,613.0,9.1e-265,914.1,sp|O97125|HSP68_DROME Heat shock protein 68 OS=Drosophila melanogaster OX=7227 GN=Hsp68 PE=1 SV=1,,,,,,
OG_05531,1.1464492222692573,FUN_024682-T1,Peve_00012723,Pocillopora_meandrina_HIv1___RNAseq.g18950.t1,three_way,76.55683333333333,FUN_024682-T1,Q17QB7,RAB30_BOVIN,,Ras-related protein Rab-30 (EC 3.6.5.2),Bos taurus (Bovine),53.8,184.0,3.0999999999999996e-55,216.5,sp|Q17QB7|RAB30_BOVIN Ras-related protein Rab-30 OS=Bos taurus OX=9913 GN=RAB30 PE=2 SV=1,GO:0003924; GO:0005525; GO:0005801; GO:0005802; GO:0007030; GO:0016020; GO:0016192; GO:0031985; GO:0032482,Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192],cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; trans-Golgi network [GO:0005802],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0016192; GO:0016787; GO:0043226,catalytic activity; GTPase activity; vesicle-mediated transport; hydrolase activity; organelle
OG_04693,1.1300638947327373,FUN_022485-T1,Peve_00002925,Pocillopora_meandrina_HIv1___RNAseq.g4293.t1,three_way,88.12733333333333,,,,,,,,,,,,,,,,,
OG_01642,1.1074286323750837,FUN_006790-T1,Peve_00028070,Pocillopora_meandrina_HIv1___RNAseq.g20501.t1,three_way,54.868,FUN_006790-T1,P35918,,,,,31.5,961.0,9.8e-99,363.6,sp|P35918|VGFR2_MOUSE Vascular endothelial growth factor receptor 2 OS=Mus musculus OX=10090 GN=Kdr PE=1 SV=2,,,,,,
OG_04999,1.0936755165600034,FUN_023134-T1,Peve_00008524,Pocillopora_meandrina_HIv1___RNAseq.g1753.t1,three_way,84.611,FUN_023134-T1,P26632,EGR1_DANRE,,Early growth response protein 1 (EGR-1) (Zinc finger protein Krox-24),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,125.0,1.4e-15,85.5,sp|P26632|EGR1_DANRE Early growth response protein 1 OS=Danio rerio OX=7955 GN=egr1 PE=2 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0010385; GO:0010842; GO:0032922; GO:0043010; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0048703; GO:0060059; GO:1990841,camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_03250,1.0929519169062327,FUN_012970-T1,Peve_00000426,Pocillopora_meandrina_HIv1___RNAseq.g12971.t1,three_way,92.84033333333332,FUN_012970-T1,A1Z6E0,GUS_DROME,,Protein gustavus,Drosophila melanogaster (Fruit fly),59.8,281.0,4.3e-97,355.9,sp|A1Z6E0|GUS_DROME Protein gustavus OS=Drosophila melanogaster OX=7227 GN=gus PE=1 SV=2,GO:0005634; GO:0005737; GO:0005938; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0008354; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449,cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; wing disc morphogenesis [GO:0007472],cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005],,GO:0005634; GO:0022414; GO:0030163; GO:0043226; GO:0048856; GO:0048870,nucleus; reproductive process; protein catabolic process; organelle; anatomical structure development; cell motility
OG_06279,1.051457704392197,FUN_028447-T1,Peve_00026233,Pocillopora_meandrina_HIv1___RNAseq.g16195.t1,three_way,59.692,FUN_028447-T1,Q60997,DMBT1_MOUSE,,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Apactin) (CRP-ductin) (Deleted in malignant brain tumors 1 protein) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80),Mus musculus (Mouse),40.3,573.0,9.700000000000001e-117,423.7,sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2,GO:0001824; GO:0001833; GO:0002065; GO:0005576; GO:0009617; GO:0015031; GO:0030658; GO:0030858; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830; GO:0062023,blastocyst development [GO:0001824]; columnar/cuboidal epithelial cell differentiation [GO:0002065]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589],zymogen binding [GO:0035375],GO:0005576; GO:0030154; GO:0030312; GO:0031012; GO:0048856,extracellular region; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_09540,1.0499233047400889,FUN_041634-T1,Peve_00023645,Pocillopora_meandrina_HIv1___RNAseq.g14222.t1,three_way,82.26466666666667,FUN_041634-T1,Q9H0K1,SIK2_HUMAN,,Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2),Homo sapiens (Human),46.9,631.0,4.8999999999999996e-135,483.4,sp|Q9H0K1|SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens OX=9606 GN=SIK2 PE=1 SV=1,GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0006468; GO:0035556; GO:0046626; GO:0046777; GO:0106310,intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03743,1.0480214371742729,FUN_015050-T1,Peve_00001172,Pocillopora_meandrina_HIv1___RNAseq.g21265.t1,three_way,70.01583333333333,FUN_015050-T1,Q8CHW5,,,,,38.3,120.0,7.4e-10,67.4,sp|Q8CHW5|BICL2_MOUSE BICD family-like cargo adapter 2 OS=Mus musculus OX=10090 GN=Bicdl2 PE=1 SV=1,,,,,,
OG_08557,1.0007836814229616,FUN_037545-T1,Peve_00032229,Pocillopora_meandrina_HIv1___RNAseq.g1633.t2,three_way,65.51433333333333,FUN_037545-T1,P60483,,,,,47.9,382.0,1.2e-98,361.7,"sp|P60483|PTEN_CANLF Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Canis lupus familiaris OX=9615 GN=PTEN PE=2 SV=1",,,,,,
OG_01576,0.9960147312958092,FUN_006581-T1,Peve_00015613,Pocillopora_meandrina_HIv1___RNAseq.g20271.t1,three_way,58.029,FUN_006581-T1,P18460,,,,,34.3,769.0,1.3e-91,339.3,sp|P18460|FGFR3_CHICK Fibroblast growth factor receptor 3 OS=Gallus gallus OX=9031 GN=FGFR3 PE=2 SV=1,,,,,,
OG_03086,0.9889497787381007,FUN_012359-T1,Peve_00042556,Pocillopora_meandrina_HIv1___RNAseq.g23272.t1,three_way,74.21950000000001,FUN_012359-T1,Q9UDY4,DNJB4_HUMAN,,DnaJ homolog subfamily B member 4 (Heat shock 40 kDa protein 1 homolog) (HSP40 homolog) (Heat shock protein 40 homolog) (Human liver DnaJ-like protein),Homo sapiens (Human),45.7,341.0,5.000000000000001e-81,302.8,sp|Q9UDY4|DNJB4_HUMAN DnaJ homolog subfamily B member 4 OS=Homo sapiens OX=9606 GN=DNAJB4 PE=1 SV=1,GO:0000122; GO:0001671; GO:0005654; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0030018; GO:0051082; GO:0051085; GO:0051087,chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Z disc [GO:0030018],ATPase activator activity [GO:0001671]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0098772,nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; molecular function regulator activity
OG_01868,0.9881546248759964,FUN_007834-T1,Peve_00003993,Pocillopora_meandrina_HIv1___RNAseq.g18432.t1b,three_way,72.9755,FUN_007834-T1,Q3UFK8,,,,,35.4,378.0,1.6e-61,238.4,sp|Q3UFK8|FRMD8_MOUSE FERM domain-containing protein 8 OS=Mus musculus OX=10090 GN=Frmd8 PE=1 SV=2,,,,,,
OG_01897,0.984004630242232,FUN_007904-T1,Peve_00040656,Pocillopora_meandrina_HIv1___RNAseq.g30059.t1,three_way,60.9685,FUN_007904-T1,P06582,,,,,37.0,100.0,1.1e-11,72.0,sp|P06582|HSP12_CAEEL Heat shock protein hsp-16.2 OS=Caenorhabditis elegans OX=6239 GN=hsp-16.2 PE=2 SV=1,,,,,,
OG_02805,0.9782675585110384,FUN_011776-T1,Peve_00006118,Pocillopora_meandrina_HIv1___RNAseq.g23292.t1,three_way,81.48183333333333,FUN_011776-T1,Q01196,RUNX1_HUMAN,,Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit),Homo sapiens (Human),48.8,320.0,7.1e-71,269.6,sp|Q01196|RUNX1_HUMAN Runt-related transcription factor 1 OS=Homo sapiens OX=9606 GN=RUNX1 PE=1 SV=3,GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001503; GO:0002062; GO:0002573; GO:0003677; GO:0003700; GO:0005509; GO:0005524; GO:0005634; GO:0005654; GO:0006357; GO:0010755; GO:0016513; GO:0030097; GO:0030099; GO:0030182; GO:0030853; GO:0030854; GO:0032743; GO:0032967; GO:0042803; GO:0043231; GO:0043371; GO:0043378; GO:0045595; GO:0045766; GO:0045893; GO:0045944; GO:0046982; GO:0048935; GO:0060043; GO:0061026; GO:0071425; GO:0140297; GO:1903055; GO:1905203,"cardiac muscle tissue regeneration [GO:0061026]; chondrocyte differentiation [GO:0002062]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ossification [GO:0001503]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell differentiation [GO:0045595]; regulation of connective tissue replacement [GO:1905203]; regulation of plasminogen activation [GO:0010755]; regulation of transcription by RNA polymerase II [GO:0006357]",chromatin [GO:0000785]; core-binding factor complex [GO:0016513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05794,0.9755822037715794,FUN_025775-T1,Peve_00012555,Pocillopora_meandrina_HIv1___RNAseq.g10363.t1,three_way,91.0985,FUN_025775-T1,P79145,,,,,50.4,254.0,2.7e-39,164.1,sp|P79145|CREM_CANLF cAMP-responsive element modulator OS=Canis lupus familiaris OX=9615 GN=CREM PE=2 SV=2,,,,,,
OG_02998,0.9723140594472665,FUN_012177-T1,Peve_00040996,Pocillopora_meandrina_HIv1___RNAseq.g23859.t1,three_way,91.90766666666669,FUN_012177-T1,P18654,KS6A3_MOUSE,,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),Mus musculus (Mouse),67.4,742.0,1e-291,1003.8,sp|P18654|KS6A3_MOUSE Ribosomal protein S6 kinase alpha-3 OS=Mus musculus OX=10090 GN=Rps6ka3 PE=1 SV=2,GO:0000287; GO:0002224; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0019901; GO:0032496; GO:0035556; GO:0043066; GO:0045944; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09120,0.9613257340394884,FUN_039266-T1,Peve_00002772,Pocillopora_meandrina_HIv1___RNAseq.g13577.t1,three_way,76.14266666666667,FUN_039266-T1,P12394,,,,,43.7,462.0,3.8999999999999998e-109,396.7,"sp|P12394|CP17A_CHICK Steroid 17-alpha-hydroxylase/17,20 lyase OS=Gallus gallus OX=9031 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_01349,0.9550724906552792,FUN_005251-T1,Peve_00003359,Pocillopora_meandrina_HIv1___RNAseq.g8148.t1,three_way,73.81333333333333,FUN_005251-T1,A4UTP7,MEF2C_PIG,,Myocyte-specific enhancer factor 2C,Sus scrofa (Pig),48.2,305.0,3.9e-58,227.3,sp|A4UTP7|MEF2C_PIG Myocyte-specific enhancer factor 2C OS=Sus scrofa OX=9823 GN=MEF2C PE=2 SV=1,GO:0000122; GO:0000165; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001568; GO:0001649; GO:0001782; GO:0001947; GO:0001958; GO:0001974; GO:0002062; GO:0002467; GO:0002634; GO:0003138; GO:0003139; GO:0003151; GO:0003185; GO:0003211; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006959; GO:0007507; GO:0007519; GO:0007521; GO:0007611; GO:0010628; GO:0010629; GO:0014033; GO:0016528; GO:0016607; GO:0030182; GO:0030220; GO:0030279; GO:0030318; GO:0030501; GO:0030890; GO:0032991; GO:0035051; GO:0035984; GO:0042100; GO:0043524; GO:0045652; GO:0045663; GO:0045666; GO:0045669; GO:0045893; GO:0045944; GO:0046983; GO:0048643; GO:0048666; GO:0050853; GO:0051145; GO:0055012; GO:0060025; GO:0060045; GO:0061333; GO:0071222; GO:0071277; GO:0071374; GO:0071466; GO:0071498; GO:0071560; GO:0072102; GO:0072160; GO:2000111; GO:2000727; GO:2000987; GO:2001013; GO:2001016,B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cardiac ventricle formation [GO:0003211]; cardiocyte differentiation [GO:0035051]; cellular response to calcium ion [GO:0071277]; cellular response to fluid shear stress [GO:0071498]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to trichostatin A [GO:0035984]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; endochondral ossification [GO:0001958]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; germinal center formation [GO:0002467]; glomerulus morphogenesis [GO:0072102]; heart development [GO:0007507]; heart looping [GO:0001947]; humoral immune response [GO:0006959]; learning or memory [GO:0007611]; MAPK cascade [GO:0000165]; melanocyte differentiation [GO:0030318]; muscle cell fate determination [GO:0007521]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule epithelial cell differentiation [GO:0072160]; neural crest cell differentiation [GO:0014033]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; platelet formation [GO:0030220]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary heart field specification [GO:0003138]; regulation of germinal center formation [GO:0002634]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of synaptic activity [GO:0060025]; renal tubule morphogenesis [GO:0061333]; secondary heart field specification [GO:0003139]; sinoatrial valve morphogenesis [GO:0003185]; skeletal muscle tissue development [GO:0007519]; smooth muscle cell differentiation [GO:0051145]; ventricular cardiac muscle cell differentiation [GO:0055012],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sarcoplasm [GO:0016528],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]",GO:0002376; GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140110,immune system process; DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nervous system process; transcription regulator activity
OG_06047,0.948036045076433,FUN_026715-T1,Peve_00018524,Pocillopora_meandrina_HIv1___TS.g19669.t1,three_way,89.792,,,,,,,,,,,,,,,,,
OG_04278,0.94674010151139,FUN_017839-T1,Peve_00011466,Pocillopora_meandrina_HIv1___RNAseq.g9632.t1,three_way,66.87983333333334,FUN_017839-T1,Q9BYW2,,,,,31.0,1246.0,5.6e-130,467.2,sp|Q9BYW2|SETD2_HUMAN Histone-lysine N-methyltransferase SETD2 OS=Homo sapiens OX=9606 GN=SETD2 PE=1 SV=3,,,,,,
OG_00877,0.9430124668243818,FUN_004170-T1,Peve_00031564,Pocillopora_meandrina_HIv1___RNAseq.g16738.t1,three_way,85.395,,,,,,,,,,,,,,,,,
OG_03558,0.9383552783571693,FUN_014704-T1,Peve_00021212,Pocillopora_meandrina_HIv1___RNAseq.g22535.t1,three_way,50.87083333333333,,,,,,,,,,,,,,,,,
OG_03779,0.9362401953066526,FUN_015109-T1,Peve_00024001,Pocillopora_meandrina_HIv1___RNAseq.g21738.t1,three_way,67.93483333333333,FUN_015109-T1,Q9QXZ0,MACF1_MOUSE,,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 (Actin cross-linking family 7)",Mus musculus (Mouse),25.3,2944.0,1.6e-256,890.6,"sp|Q9QXZ0|MACF1_MOUSE Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 OS=Mus musculus OX=10090 GN=Macf1 PE=1 SV=2",GO:0001707; GO:0003779; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005938; GO:0006620; GO:0007163; GO:0008017; GO:0008104; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0051011; GO:0051015; GO:0051893; GO:0150011,cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587],actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011],GO:0003824; GO:0005794; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016787; GO:0042060; GO:0043226; GO:0048870; GO:0072659,catalytic activity; Golgi apparatus; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; wound healing; organelle; cell motility; protein localization to plasma membrane
OG_07343,0.936001961667441,FUN_033748-T1,Peve_00004932,Pocillopora_meandrina_HIv1___RNAseq.g28754.t1,three_way,36.10916666666667,,,,,,,,,,,,,,,,,
OG_05486,0.9315739337179346,FUN_024483-T1,Peve_00010585,Pocillopora_meandrina_HIv1___RNAseq.g19068.t1,three_way,49.94483333333333,FUN_024483-T1,Q9UHB7,,,,,27.0,248.0,1.4e-13,80.5,sp|Q9UHB7|AFF4_HUMAN AF4/FMR2 family member 4 OS=Homo sapiens OX=9606 GN=AFF4 PE=1 SV=1,,,,,,
OG_09694,0.9310416985887406,FUN_041923-T1,Peve_00007865,Pocillopora_meandrina_HIv1___RNAseq.g15625.t1,three_way,75.917,FUN_041923-T1,D6C652,YAP1A_XENLA,,Transcriptional coactivator YAP1-A (Yes-associated protein 1-A) (xYAP) (Protein yorkie homolog-A) (Yes-associated protein YAP65 homolog A),Xenopus laevis (African clawed frog),28.5,456.0,6.000000000000001e-28,126.7,sp|D6C652|YAP1A_XENLA Transcriptional coactivator YAP1-A OS=Xenopus laevis OX=8355 GN=yap1-a PE=1 SV=1,GO:0003713; GO:0003714; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0035329; GO:0045944,hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005886; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; plasma membrane; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_02341,0.928593627560917,FUN_008940-T1,Peve_00007194,Pocillopora_meandrina_HIv1___TS.g30103.t1,three_way,71.29533333333333,FUN_008940-T1,P31422,GRM3_RAT,,Metabotropic glutamate receptor 3 (mGluR3),Rattus norvegicus (Rat),41.0,808.0,1.2999999999999998e-173,611.7,sp|P31422|GRM3_RAT Metabotropic glutamate receptor 3 OS=Rattus norvegicus OX=10116 GN=Grm3 PE=1 SV=1,GO:0001641; GO:0005246; GO:0005886; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0033554; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170,"cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]",astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110],GO:0005886; GO:0043226; GO:0050877; GO:0060089; GO:0098772,plasma membrane; organelle; nervous system process; molecular transducer activity; molecular function regulator activity
OG_03335,0.9269074212784404,FUN_013556-T1,Peve_00038569,Pocillopora_meandrina_HIv1___RNAseq.g22960.t1,three_way,59.44166666666667,FUN_013556-T1,Q6NR09,EGRAP_DROME,,EGFR adapter protein,Drosophila melanogaster (Fruit fly),34.3,137.0,7.7e-13,77.0,sp|Q6NR09|EGRAP_DROME EGFR adapter protein OS=Drosophila melanogaster OX=7227 GN=Egfrap PE=1 SV=1,GO:0005925; GO:0030971; GO:0042059; GO:0045179,negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059],apical cortex [GO:0045179]; focal adhesion [GO:0005925],receptor tyrosine kinase binding [GO:0030971],,
OG_08952,0.9245489596373816,FUN_038426-T1,Peve_00000114,Pocillopora_meandrina_HIv1___RNAseq.g1178.t1,three_way,77.04633333333334,FUN_038426-T1,F1R8Z9,FXJ1B_DANRE,,Forkhead box protein J1-B,Danio rerio (Zebrafish) (Brachydanio rerio),45.4,282.0,2.2e-51,204.5,sp|F1R8Z9|FXJ1B_DANRE Forkhead box protein J1-B OS=Danio rerio OX=7955 GN=foxj1b PE=2 SV=1,GO:0000978; GO:0000981; GO:0001947; GO:0003146; GO:0005634; GO:0006357; GO:0007368; GO:0044458; GO:0060088; GO:0060271,auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; heart looping [GO:0001947]; motile cilium assembly [GO:0044458]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0044782; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; cilium organization; transcription regulator activity
OG_07121,0.9228678644140614,FUN_032420-T1,Peve_00041753,Pocillopora_meandrina_HIv1___RNAseq.g24395.t1,three_way,71.22583333333333,,,,,,,,,,,,,,,,,
OG_06416,0.9187856077889248,FUN_029099-T1,Peve_00038062,Pocillopora_meandrina_HIv1___RNAseq.g25485.t1,three_way,55.33266666666667,FUN_029099-T1,P20105,E74EA_DROME,,Ecdysone-induced protein 74EF isoform A (ETS-related protein E74A),Drosophila melanogaster (Fruit fly),52.4,105.0,3.5e-21,103.6,sp|P20105|E74EA_DROME Ecdysone-induced protein 74EF isoform A OS=Drosophila melanogaster OX=7227 GN=Eip74EF PE=2 SV=2,GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006914; GO:0030154; GO:0040034; GO:0043565; GO:0045944; GO:0048102; GO:0048477,"autophagic cell death [GO:0048102]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]",nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0006914; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; autophagy; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_01210,0.9152347688744542,FUN_004887-T1,Peve_00005850,Pocillopora_meandrina_HIv1___RNAseq.g10661.t1,three_way,61.143166666666666,FUN_004887-T1,A0A0R4IBK5,R213A_DANRE,,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha),Danio rerio (Zebrafish) (Brachydanio rerio),31.4,1097.0,1.9e-124,450.7,sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1,GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051,blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005730; GO:0005811; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"immune system process; circulatory system process; catalytic activity; nucleolus; lipid droplet; cytosol; lipid metabolic process; autophagy; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_09798,0.9138661043979116,FUN_042606-T1,Peve_00034915,Pocillopora_meandrina_HIv1___RNAseq.g16848.t1,three_way,70.83866666666667,FUN_042606-T1,O77627,,,,,34.6,318.0,4.900000000000003e-22,107.5,sp|O77627|JUN_BOVIN Transcription factor Jun OS=Bos taurus OX=9913 GN=JUN PE=2 SV=2,,,,,,
OG_01495,0.9132097127656892,FUN_006218-T1,Peve_00020212,Pocillopora_meandrina_HIv1___RNAseq.g20436.t1,three_way,60.865,,,,,,,,,,,,,,,,,
OG_00356,0.9131743833003244,FUN_001188-T1,Peve_00009673,Pocillopora_meandrina_HIv1___TS.g6724.t2,three_way,43.03966666666667,,,,,,,,,,,,,,,,,
OG_04983,0.9074518431944724,FUN_023110-T1,Peve_00000494,Pocillopora_meandrina_HIv1___RNAseq.g1701.t2,three_way,63.913,FUN_023110-T1,Q8IUR6,,,,,61.0,59.0,2e-11,71.6,sp|Q8IUR6|CRERF_HUMAN CREB3 regulatory factor OS=Homo sapiens OX=9606 GN=CREBRF PE=1 SV=2,,,,,,
OG_10052,0.8991349286288478,FUN_043326-T1,Peve_00043041,Pocillopora_meandrina_HIv1___RNAseq.g8953.t1,three_way,56.76033333333333,FUN_043326-T1,D3ZAZ5,BCAR3_RAT,,"Breast cancer anti-estrogen resistance protein 3 homolog (BCAR3 adapter protein, NSP family member) (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B) (p130Cas-binding protein AND-34)",Rattus norvegicus (Rat),23.4,785.0,4.2e-25,118.2,sp|D3ZAZ5|BCAR3_RAT Breast cancer anti-estrogen resistance protein 3 homolog OS=Rattus norvegicus OX=10116 GN=Bcar3 PE=1 SV=1,GO:0001784; GO:0002089; GO:0005085; GO:0005737; GO:0005925; GO:0007173; GO:0007264; GO:0008284; GO:0008286; GO:0016020; GO:0019900; GO:0043410; GO:0043547; GO:0086100,endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020],guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784],GO:0098772,molecular function regulator activity
OG_09472,0.897871752764677,FUN_041498-T1,Peve_00007700,Pocillopora_meandrina_HIv1___TS.g10682.t1,three_way,80.48866666666666,FUN_041498-T1,Q6Q2B2,,,,,39.5,253.0,1.1e-33,145.6,sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1,,,,,,
OG_04261,0.8977850429141099,FUN_017807-T1,Peve_00040756,Pocillopora_meandrina_HIv1___RNAseq.g9535.t2,three_way,73.905,FUN_017807-T1,Q80TE4,,,,,54.0,767.0,3.7e-223,777.3,sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3,,,,,,
OG_04261,0.8977850429141099,FUN_017807-T1,Peve_00040756,Pocillopora_meandrina_HIv1___RNAseq.g9535.t2,three_way,73.905,FUN_017807-T1,Q80TE4,,,,,38.5,78.0,0.002,47.4,sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3,,,,,,
OG_03971,0.8971393614314626,FUN_016125-T1,Peve_00013452,Pocillopora_meandrina_HIv1___RNAseq.g21531.t1,three_way,80.723,FUN_016125-T1,Q8VI36,PAXI_MOUSE,,Paxillin,Mus musculus (Mouse),52.0,471.0,3.8e-133,476.5,sp|Q8VI36|PAXI_MOUSE Paxillin OS=Mus musculus OX=10090 GN=Pxn PE=1 SV=1,GO:0005078; GO:0005856; GO:0005925; GO:0005938; GO:0007010; GO:0007179; GO:0007229; GO:0008360; GO:0016477; GO:0030027; GO:0030032; GO:0030159; GO:0031252; GO:0031663; GO:0034446; GO:0038191; GO:0045766; GO:0046872; GO:0048041; GO:0048754; GO:0051435; GO:1900026,branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of angiogenesis [GO:0045766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179],cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027],BH4 domain binding [GO:0051435]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; signaling receptor complex adaptor activity [GO:0030159],GO:0005856; GO:0007010; GO:0007155; GO:0034330; GO:0043226; GO:0048870; GO:0060090,cytoskeleton; cytoskeleton organization; cell adhesion; cell junction organization; organelle; cell motility; molecular adaptor activity
OG_01496,0.8914156498751715,FUN_006220-T1,Peve_00020217,Pocillopora_meandrina_HIv1___RNAseq.g20437.t1,three_way,69.87716666666667,FUN_006220-T1,P83094,STIM_DROME,,Stromal interaction molecule homolog,Drosophila melanogaster (Fruit fly),37.4,390.0,8.200000000000001e-59,229.9,sp|P83094|STIM_DROME Stromal interaction molecule homolog OS=Drosophila melanogaster OX=7227 GN=Stim PE=1 SV=1,GO:0002115; GO:0005246; GO:0005509; GO:0005513; GO:0005783; GO:0005789; GO:0005886; GO:0006874; GO:0007476; GO:0012505; GO:0015279; GO:0016020; GO:0022416; GO:0048763; GO:0051924; GO:0140268,chaeta development [GO:0022416]; detection of calcium ion [GO:0005513]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular calcium ion homeostasis [GO:0006874]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; store-operated calcium channel activity [GO:0015279],GO:0005215; GO:0005783; GO:0005886; GO:0043226; GO:0048856; GO:0098772,transporter activity; endoplasmic reticulum; plasma membrane; organelle; anatomical structure development; molecular function regulator activity
OG_06436,0.8884273754314643,FUN_029130-T1,Peve_00033155,Pocillopora_meandrina_HIv1___RNAseq.g25785.t1,three_way,48.33016666666666,,,,,,,,,,,,,,,,,
OG_07039,0.8859392590940077,FUN_032235-T1,Peve_00043486,Pocillopora_meandrina_HIv1___RNAseq.g24841.t1,three_way,59.83833333333334,,,,,,,,,,,,,,,,,
OG_06719,0.8827513966370901,FUN_031470-T1,Peve_00026552,Pocillopora_meandrina_HIv1___RNAseq.g5082.t1,three_way,68.5885,FUN_031470-T1,Q9JLC8,,,,,30.2,4722.0,0.0,1872.1,sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2,,,,,,
OG_01895,0.8816657882138884,FUN_007895-T1,Peve_00009865,Pocillopora_meandrina_HIv1___RNAseq.g18241.t1a,three_way,47.54166666666666,,,,,,,,,,,,,,,,,
OG_05253,0.8782192063171554,FUN_023701-T1,Peve_00017415,Pocillopora_meandrina_HIv1___RNAseq.g17594.t1,three_way,79.94866666666667,FUN_023701-T1,Q8IYX7,SAXO1_HUMAN,,Stabilizer of axonemal microtubules 1,Homo sapiens (Human),21.5,498.0,2.4e-12,75.1,sp|Q8IYX7|SAXO1_HUMAN Stabilizer of axonemal microtubules 1 OS=Homo sapiens OX=9606 GN=SAXO1 PE=1 SV=2,GO:0005813; GO:0005814; GO:0005856; GO:0005879; GO:0008017; GO:0009631; GO:0030030; GO:0031514; GO:0036064; GO:0036126; GO:0045724; GO:0050821; GO:0070417,cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821],axonemal microtubule [GO:0005879]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],microtubule binding [GO:0008017],GO:0005815; GO:0005856; GO:0005929; GO:0008092; GO:0043226,microtubule organizing center; cytoskeleton; cilium; cytoskeletal protein binding; organelle
OG_06891,0.8775658830030205,FUN_031930-T1,Peve_00004237,Pocillopora_meandrina_HIv1___RNAseq.g18237.t1,three_way,54.86833333333333,,,,,,,,,,,,,,,,,
OG_08898,0.8765192803509508,FUN_038311-T1,Peve_00020693,Pocillopora_meandrina_HIv1___RNAseq.g1142.t1,three_way,76.04366666666667,FUN_038311-T1,Q8R5K6,,,,,43.3,217.0,3.7999999999999996e-39,163.3,sp|Q8R5K6|TOB1_RAT Protein Tob1 OS=Rattus norvegicus OX=10116 GN=Tob1 PE=1 SV=1,,,,,,
OG_01275,0.8741377482059071,FUN_005053-T1,Peve_00016727,Pocillopora_meandrina_HIv1___RNAseq.g8306.t2,three_way,75.827,FUN_005053-T1,Q9BRS8,LARP6_HUMAN,,La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6),Homo sapiens (Human),30.5,442.0,8e-37,156.4,sp|Q9BRS8|LARP6_HUMAN La-related protein 6 OS=Homo sapiens OX=9606 GN=LARP6 PE=1 SV=1,GO:0003729; GO:0005634; GO:0005737; GO:0006396; GO:0006417; GO:0017022; GO:0032967; GO:0035613; GO:0048027; GO:1990825; GO:1990904,positive regulation of collagen biosynthetic process [GO:0032967]; regulation of translation [GO:0006417]; RNA processing [GO:0006396],cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0008092; GO:0043226,RNA binding; nucleus; cytoskeletal protein binding; organelle
OG_03309,0.8718160745075048,FUN_013385-T1,Peve_00015992,Pocillopora_meandrina_HIv1___RNAseq.g22980.t2,three_way,65.83083333333333,FUN_013385-T1,Q24180,DEAF1_DROME,,Deformed epidermal autoregulatory factor 1 (Protein DEAF-1),Drosophila melanogaster (Fruit fly),45.2,84.0,2.6e-16,87.8,sp|Q24180|DEAF1_DROME Deformed epidermal autoregulatory factor 1 OS=Drosophila melanogaster OX=7227 GN=Deaf1 PE=1 SV=1,GO:0000981; GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0008270; GO:0009792; GO:0043565; GO:0045893; GO:0050776,embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]; polytene chromosome [GO:0005700],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005694; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; chromosome; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_09597,0.8711750735279051,FUN_041744-T1,Peve_00000340,Pocillopora_meandrina_HIv1___RNAseq.g15789.t1,three_way,72.12516666666667,,,,,,,,,,,,,,,,,
OG_03085,0.8685904674793434,FUN_012358-T1,Peve_00042557,Pocillopora_meandrina_HIv1___RNAseq.g23273.t1,three_way,74.58133333333333,FUN_012358-T1,Q24133,DNAJ1_DROME,,DnaJ protein homolog 1 (DROJ1),Drosophila melanogaster (Fruit fly),53.0,332.0,1.4e-84,314.7,sp|Q24133|DNAJ1_DROME DnaJ protein homolog 1 OS=Drosophila melanogaster OX=7227 GN=DnaJ-1 PE=1 SV=3,GO:0005829; GO:0006457; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087; GO:0140297,chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408],cytosol [GO:0005829],DNA-binding transcription factor binding [GO:0140297]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0005829; GO:0006457,cytosol; protein folding
OG_08878,0.8658776283183085,FUN_038277-T1,Peve_00041700,Pocillopora_meandrina_HIv1___TS.g8098.t1,three_way,74.06316666666667,FUN_038277-T1,Q0V8S9,,,,,34.8,135.0,1.4e-13,84.7,sp|Q0V8S9|CNTP5_CHICK Contactin-associated protein-like 5 OS=Gallus gallus OX=9031 GN=CNTNAP5 PE=2 SV=1,,,,,,
OG_01995,0.8584625112131881,FUN_008104-T1,Peve_00019588,Pocillopora_meandrina_HIv1___RNAseq.g17898.t1,three_way,90.90516666666667,FUN_008104-T1,O57521,HS90B_DANRE,,Heat shock protein HSP 90-beta,Danio rerio (Zebrafish) (Brachydanio rerio),82.0,727.0,2.3e-304,1045.8,sp|O57521|HS90B_DANRE Heat shock protein HSP 90-beta OS=Danio rerio OX=7955 GN=hsp90ab1 PE=1 SV=2,GO:0001568; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0007517; GO:0016887; GO:0030511; GO:0032435; GO:0032991; GO:0034605; GO:0034751; GO:0043627; GO:0046983; GO:0048471; GO:0050821; GO:0050900; GO:0051082; GO:0051726; GO:0120293; GO:0140662; GO:0141069,blood vessel development [GO:0001568]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; response to estrogen [GO:0043627],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein dimerization activity [GO:0046983]; receptor ligand inhibitor activity [GO:0141069]; unfolded protein binding [GO:0051082],GO:0002376; GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0048856; GO:0048870; GO:0098772; GO:0140657,immune system process; catalytic activity; extracellular region; nucleus; cytosol; plasma membrane; protein folding; hydrolase activity; organelle; protein folding chaperone; anatomical structure development; cell motility; molecular function regulator activity; ATP-dependent activity
OG_07361,0.8580091298705369,FUN_033773-T1,Peve_00005280,Pocillopora_meandrina_HIv1___RNAseq.g26658.t2,three_way,82.50433333333334,FUN_033773-T1,B9EJ86,OSBL8_MOUSE,,Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8),Mus musculus (Mouse),46.7,803.0,3.8e-197,689.9,sp|B9EJ86|OSBL8_MOUSE Oxysterol-binding protein-related protein 8 OS=Mus musculus OX=10090 GN=Osbpl8 PE=1 SV=1,GO:0001786; GO:0005789; GO:0015485; GO:0015914; GO:0030336; GO:0031965; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0070328; GO:0090204; GO:0140343,fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; phospholipid transport [GO:0015914]; positive regulation of D-glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein localization to nuclear pore [GO:0090204]; triglyceride homeostasis [GO:0070328],endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965],cholesterol binding [GO:0015485]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343],GO:0005215; GO:0008289; GO:0030154,transporter activity; lipid binding; cell differentiation
OG_02354,0.8577603859277229,FUN_008956-T1,Peve_00021626,Pocillopora_meandrina_HIv1___RNAseq.g4047.t1,three_way,86.82350000000001,FUN_008956-T1,Q9NV58,,,,,68.9,360.0,7.5e-154,545.4,sp|Q9NV58|RN19A_HUMAN E3 ubiquitin-protein ligase RNF19A OS=Homo sapiens OX=9606 GN=RNF19A PE=1 SV=3,,,,,,
OG_05138,0.8551266539824057,FUN_023410-T1,Peve_00017394,Pocillopora_meandrina_HIv1___RNAseq.g17575.t1,three_way,54.03783333333333,FUN_023410-T1,Q1LYG0,,,,,34.5,313.0,3.9e-50,201.8,sp|Q1LYG0|SPD2A_DANRE SH3 and PX domain-containing protein 2A OS=Danio rerio OX=7955 GN=sh3pxd2a PE=3 SV=2,,,,,,
OG_07222,0.8510214820697971,FUN_032815-T1,Peve_00014570,Pocillopora_meandrina_HIv1___RNAseq.g29707.t1,three_way,69.17233333333334,FUN_032815-T1,Q5HYM0,ZC12B_HUMAN,,Probable ribonuclease ZC3H12B (EC 3.1.-.-) (MCP-induced protein 2) (Zinc finger CCCH domain-containing protein 12B),Homo sapiens (Human),59.1,220.0,8.099999999999997e-69,263.1,sp|Q5HYM0|ZC12B_HUMAN Probable ribonuclease ZC3H12B OS=Homo sapiens OX=9606 GN=ZC3H12B PE=1 SV=3,GO:0003729; GO:0004521; GO:0005634; GO:0008270; GO:0036464,,cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634],mRNA binding [GO:0003729]; RNA endonuclease activity [GO:0004521]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; organelle; catalytic activity, acting on RNA"
OG_00661,0.8502811505397126,FUN_001954-T1,Peve_00024484,Pocillopora_meandrina_HIv1___RNAseq.g29228.t1,three_way,86.64866666666667,FUN_001954-T1,Q6FIF0,ZFAN6_HUMAN,,AN1-type zinc finger protein 6 (Associated with PRK1 protein) (Zinc finger A20 domain-containing protein 3),Homo sapiens (Human),38.9,208.0,1.9e-29,130.6,sp|Q6FIF0|ZFAN6_HUMAN AN1-type zinc finger protein 6 OS=Homo sapiens OX=9606 GN=ZFAND6 PE=1 SV=2,GO:0003677; GO:0005829; GO:0006625; GO:0006915; GO:0008270; GO:0015031; GO:0031593; GO:0043066; GO:0043122; GO:0071356,apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; protein transport [GO:0015031]; regulation of canonical NF-kappaB signal transduction [GO:0043122],cytosol [GO:0005829],DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270],GO:0003677; GO:0005829; GO:0012501,DNA binding; cytosol; programmed cell death
OG_03080,0.849241150030333,FUN_012352-T1,Peve_00042523,Pocillopora_meandrina_HIv1___RNAseq.g23279.t1,three_way,78.2095,FUN_012352-T1,Q2KIT4,,,,,47.1,365.0,5.2e-84,312.8,sp|Q2KIT4|DNJB4_BOVIN DnaJ homolog subfamily B member 4 OS=Bos taurus OX=9913 GN=DNAJB4 PE=2 SV=1,,,,,,
OG_02316,0.8480991068870675,FUN_008907-T1,Peve_00027548,Pocillopora_meandrina_HIv1___RNAseq.g3972.t1,three_way,56.05233333333333,FUN_008907-T1,Q8CH34,ZP4_RAT,,Zona pellucida sperm-binding protein 4 (Zona pellucida glycoprotein 4) (Zp-4) (Zona pellucida protein B) [Cleaved into: Processed zona pellucida sperm-binding protein 4],Rattus norvegicus (Rat),27.7,332.0,4.3e-14,80.5,sp|Q8CH34|ZP4_RAT Zona pellucida sperm-binding protein 4 OS=Rattus norvegicus OX=10116 GN=Zp4 PE=2 SV=1,GO:0002922; GO:0005576; GO:0005886; GO:0007339; GO:0032190; GO:0035804; GO:0035805; GO:0042102; GO:0042802; GO:0060468; GO:0060478; GO:0062023; GO:2000344; GO:2000360,acrosomal vesicle exocytosis [GO:0060478]; binding of sperm to zona pellucida [GO:0007339]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of humoral immune response [GO:0002922]; positive regulation of T cell proliferation [GO:0042102]; prevention of polyspermy [GO:0060468],collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],acrosin binding [GO:0032190]; identical protein binding [GO:0042802]; structural constituent of egg coat [GO:0035804],GO:0005198; GO:0005576; GO:0005886; GO:0016192; GO:0030312; GO:0031012,structural molecule activity; extracellular region; plasma membrane; vesicle-mediated transport; external encapsulating structure; extracellular matrix
OG_06592,0.847383285805188,FUN_029640-T1,Peve_00037895,Pocillopora_meandrina_HIv1___RNAseq.g17204.t1,three_way,61.37616666666666,FUN_029640-T1,A2ARV4,LRP2_MOUSE,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Mus musculus (Mouse),38.1,428.0,4.3e-50,201.4,sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1,GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0016020; GO:0016324; GO:0017124; GO:0030001; GO:0030139; GO:0030424; GO:0030425; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0034311; GO:0035904; GO:0042359; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045177; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1904888,aorta development [GO:0035904]; cell population proliferation [GO:0008283]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006629; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085,endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; lipid metabolic process; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_03825,0.8421797596289398,FUN_015245-T1,Peve_00003467,Pocillopora_meandrina_HIv1___RNAseq.g22163.t1,three_way,72.38283333333334,FUN_015245-T1,Q6VAB6,KSR2_HUMAN,,Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1),Homo sapiens (Human),33.3,953.0,6.5e-104,380.2,sp|Q6VAB6|KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens OX=9606 GN=KSR2 PE=1 SV=2,GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0008270; GO:0019722; GO:0031434; GO:0043410; GO:0106310; GO:0120162,calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0060090; GO:0140096,"catalytic activity; cytosol; plasma membrane; transferase activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_08097,0.8411824524976145,FUN_035839-T1,Peve_00032500,Pocillopora_meandrina_HIv1___RNAseq.g11958.t2,three_way,68.27866666666667,,,,,,,,,,,,,,,,,
OG_02997,0.8379275312383452,FUN_012176-T1,Peve_00040994,Pocillopora_meandrina_HIv1___RNAseq.g23858.t1,three_way,63.23466666666666,FUN_012176-T1,Q709C8,VP13C_HUMAN,,Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C),Homo sapiens (Human),24.7,4222.0,0.0,1083.2,sp|Q709C8|VP13C_HUMAN Intermembrane lipid transfer protein VPS13C OS=Homo sapiens OX=9606 GN=VPS13C PE=1 SV=1,GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005770; GO:0005789; GO:0005811; GO:0005829; GO:0006623; GO:0006869; GO:0006895; GO:0007005; GO:0031902; GO:0032127; GO:0032868; GO:0045053; GO:0070062; GO:1905090,Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of type 2 mitophagy [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741],,GO:0005764; GO:0005768; GO:0005773; GO:0005811; GO:0005829; GO:0006886; GO:0007005; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; lipid droplet; cytosol; intracellular protein transport; mitochondrion organization; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09455,0.8368884449020872,FUN_041463-T1,Peve_00013687,Pocillopora_meandrina_HIv1___RNAseq.g15689.t1,three_way,54.7395,FUN_041463-T1,Q95209,SORL_RABIT,,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA),Oryctolagus cuniculus (Rabbit),36.6,2110.0,7.4e-199,697.2,sp|Q95209|SORL_RABIT Sortilin-related receptor OS=Oryctolagus cuniculus OX=9986 GN=SORL1 PE=1 SV=1,GO:0000139; GO:0002024; GO:0005615; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0010897; GO:0014910; GO:0016020; GO:0030514; GO:0030658; GO:0031901; GO:0032585; GO:0038020; GO:0045053; GO:0046628; GO:0055038; GO:1904179; GO:1990845,adaptive thermogenesis [GO:1990845]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658],,GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226,extracellular space; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_04652,0.8367604347225651,FUN_022389-T1,Peve_00037602,Pocillopora_meandrina_HIv1___TS.g19607.t1,three_way,66.46,FUN_022389-T1,D3Z2X2,DNHD1_MOUSE,,Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein),Mus musculus (Mouse),22.8,4456.0,4.4999999999999995e-257,891.3,sp|D3Z2X2|DNHD1_MOUSE Dynein heavy chain domain-containing protein 1 OS=Mus musculus OX=10090 GN=Dnhd1 PE=1 SV=3,GO:0005524; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0045505; GO:0051959; GO:0120316,flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316],dynein complex [GO:0030286]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; isomerase activity; reproductive process; organelle; cilium organization; cell motility; ATP-dependent activity
OG_04516,0.8343073979080753,FUN_022049-T1,Peve_00032394,Pocillopora_meandrina_HIv1___RNAseq.g4599.t1,three_way,67.69266666666667,FUN_022049-T1,Q9C098,DCLK3_HUMAN,,Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3),Homo sapiens (Human),59.1,269.0,2e-91,338.6,sp|Q9C098|DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens OX=9606 GN=DCLK3 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0034504; GO:0106310,protein localization to nucleus [GO:0034504],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02112,0.8324530630772112,FUN_008397-T1,Peve_00043603,Pocillopora_meandrina_HIv1___RNAseq.g6179.t1,three_way,31.29733333333333,FUN_008397-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),35.4,99.0,4.4e-07,60.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_05323,0.8316315927907633,FUN_024015-T1,Peve_00040419,Pocillopora_meandrina_HIv1___RNAseq.g19286.t1,three_way,70.89716666666666,FUN_024015-T1,Q6ZR37,PKHG7_HUMAN,,Pleckstrin homology domain-containing family G member 7 (PH domain-containing family G member 7),Homo sapiens (Human),35.4,540.0,1.8e-73,279.3,sp|Q6ZR37|PKHG7_HUMAN Pleckstrin homology domain-containing family G member 7 OS=Homo sapiens OX=9606 GN=PLEKHG7 PE=1 SV=2,GO:0005085; GO:0007266,Rho protein signal transduction [GO:0007266],,guanyl-nucleotide exchange factor activity [GO:0005085],GO:0098772,molecular function regulator activity
OG_09178,0.8313999550759155,FUN_039858-T1,Peve_00020641,Pocillopora_meandrina_HIv1___RNAseq.g7287.t1a,three_way,34.05316666666667,,,,,,,,,,,,,,,,,
OG_07714,0.8273661551073854,FUN_034867-T1,Peve_00005778,Pocillopora_meandrina_HIv1___RNAseq.g27146.t1,three_way,75.34383333333334,FUN_034867-T1,Q28193,FURIN_BOVIN,,Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE) (Trans Golgi network protease furin),Bos taurus (Bovine),49.8,616.0,5.7e-165,582.8,sp|Q28193|FURIN_BOVIN Furin OS=Bos taurus OX=9913 GN=FURIN PE=1 SV=1,GO:0000139; GO:0004252; GO:0005576; GO:0005802; GO:0005886; GO:0008201; GO:0010008; GO:0016486; GO:0046872; GO:0140447; GO:1904399,cytokine precursor processing [GO:0140447]; peptide hormone processing [GO:0016486],endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_04385,0.8257264417489434,FUN_018091-T1,Peve_00001666,Pocillopora_meandrina_HIv1___TS.g25577.t1,three_way,73.79583333333333,FUN_018091-T1,Q6ZS30,,,,,36.6,2500.0,0.0,1536.9,sp|Q6ZS30|NBEL1_HUMAN Neurobeachin-like protein 1 OS=Homo sapiens OX=9606 GN=NBEAL1 PE=1 SV=3,,,,,,
OG_04353,0.8251999436001122,FUN_018000-T1,Peve_00044834,Pocillopora_meandrina_HIv1___RNAseq.29588_t,three_way,55.3835,FUN_018000-T1,Q8IXF0,NPAS3_HUMAN,,Neuronal PAS domain-containing protein 3 (Neuronal PAS3) (Basic-helix-loop-helix-PAS protein MOP6) (Class E basic helix-loop-helix protein 12) (bHLHe12) (Member of PAS protein 6) (PAS domain-containing protein 6),Homo sapiens (Human),40.8,424.0,9.4e-76,287.0,sp|Q8IXF0|NPAS3_HUMAN Neuronal PAS domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NPAS3 PE=1 SV=1,GO:0000785; GO:0000977; GO:0000981; GO:0005654; GO:0006357; GO:0045893; GO:0046982,positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleoplasm [GO:0005654],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005654; GO:0006355; GO:0140110,DNA binding; nucleoplasm; regulation of DNA-templated transcription; transcription regulator activity
OG_04454,0.8251590478419414,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,41.9,508.0,1.3e-103,382.9,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_04454,0.8251590478419414,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,32.7,107.0,8.6e-10,71.2,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_05353,0.8236236636810559,FUN_024124-T1,Peve_00000162,Pocillopora_meandrina_HIv1___RNAseq.g19172.t1,three_way,87.20466666666667,FUN_024124-T1,Q9Y603,,,,,37.1,62.0,8e-08,58.9,sp|Q9Y603|ETV7_HUMAN Transcription factor ETV7 OS=Homo sapiens OX=9606 GN=ETV7 PE=1 SV=1,,,,,,
OG_09650,0.820496733536515,FUN_041848-T1,Peve_00010478,Pocillopora_meandrina_HIv1___RNAseq.g15073.t1,three_way,64.9195,FUN_041848-T1,P78543,BTG2_HUMAN,,Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3),Homo sapiens (Human),41.4,116.0,4e-19,96.3,sp|P78543|BTG2_HUMAN Protein BTG2 OS=Homo sapiens OX=9606 GN=BTG2 PE=1 SV=1,GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0007405; GO:0007406; GO:0008285; GO:0008306; GO:0009612; GO:0009952; GO:0017148; GO:0021542; GO:0021954; GO:0031175; GO:0035914; GO:0043434; GO:0043524; GO:0051602; GO:0060213; GO:0070062; GO:1904628,anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neuroblast proliferation [GO:0007405]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714],GO:0005634; GO:0005829; GO:0006281; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140110,nucleus; cytosol; DNA repair; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; transcription regulator activity
OG_01193,0.8195048609945719,FUN_004851-T1,Peve_00043739,Pocillopora_meandrina_HIv1___RNAseq.g8640.t1,three_way,62.76883333333333,FUN_004851-T1,Q04912,RON_HUMAN,,Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain],Homo sapiens (Human),35.8,293.0,2.2e-49,198.7,sp|Q04912|RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens OX=9606 GN=MST1R PE=1 SV=3,GO:0001725; GO:0004714; GO:0005011; GO:0005524; GO:0005773; GO:0005886; GO:0006909; GO:0006952; GO:0007165; GO:0007169; GO:0007338; GO:0007399; GO:0008284; GO:0009615; GO:0009986; GO:0016477; GO:0019899; GO:0043235; GO:0043406; GO:0045087; GO:0051897,cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; defense response [GO:0006952]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; response to virus [GO:0009615]; signal transduction [GO:0007165]; single fertilization [GO:0007338],cell surface [GO:0009986]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; vacuole [GO:0005773],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; macrophage colony-stimulating factor receptor activity [GO:0005011]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0002376; GO:0003824; GO:0005773; GO:0005886; GO:0016192; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0098542; GO:0140096,"immune system process; catalytic activity; vacuole; plasma membrane; vesicle-mediated transport; transferase activity; reproductive process; organelle; anatomical structure development; cell motility; molecular transducer activity; defense response to other organism; catalytic activity, acting on a protein"
OG_01504,0.819456224088545,FUN_006236-T1,Peve_00011453,Pocillopora_meandrina_HIv1___RNAseq.g20448.t1,three_way,65.54733333333333,,,,,,,,,,,,,,,,,
OG_03785,0.8178960099495904,FUN_015145-T1,Peve_00001083,Pocillopora_meandrina_HIv1___RNAseq.g21746.t2,three_way,73.53316666666667,FUN_015145-T1,Q640I9,,,,,30.3,1123.0,1.7999999999999998e-141,505.0,sp|Q640I9|KDM2B_XENLA Lysine-specific demethylase 2B OS=Xenopus laevis OX=8355 GN=kdm2b PE=2 SV=1,,,,,,
OG_01212,0.8149337113438136,FUN_004891-T1,Peve_00043723,Pocillopora_meandrina_HIv1___RNAseq.g8663.t1,three_way,69.44433333333333,FUN_004891-T1,Q7T381,BOKB_DANRE,,Bcl-2-related ovarian killer protein homolog B (zBok2),Danio rerio (Zebrafish) (Brachydanio rerio),37.4,107.0,7.8e-10,65.5,sp|Q7T381|BOKB_DANRE Bcl-2-related ovarian killer protein homolog B OS=Danio rerio OX=7955 GN=bokb PE=2 SV=1,GO:0005741; GO:0006915; GO:0015267; GO:0042981,apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981],mitochondrial outer membrane [GO:0005741],channel activity [GO:0015267],GO:0005215; GO:0012501,transporter activity; programmed cell death
OG_05766,0.8146906795887524,FUN_025724-T1,Peve_00001160,Pocillopora_meandrina_HIv1___RNAseq.g10456.t1,three_way,61.71366666666667,FUN_025724-T1,Q5NUA6,NF2L2_BOVIN,,"Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2)",Bos taurus (Bovine),43.4,122.0,1e-17,93.2,sp|Q5NUA6|NF2L2_BOVIN Nuclear factor erythroid 2-related factor 2 OS=Bos taurus OX=9913 GN=NFE2L2 PE=2 SV=2,GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0010499; GO:0016567; GO:0034599; GO:0043161; GO:0043565; GO:0045088; GO:0045454; GO:0045944; GO:0071498; GO:0110076,cell redox homeostasis [GO:0045454]; cellular response to fluid shear stress [GO:0071498]; cellular response to oxidative stress [GO:0034599]; negative regulation of ferroptosis [GO:0110076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of innate immune response [GO:0045088]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0030163; GO:0043226; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; protein catabolic process; organelle; transcription regulator activity
OG_09216,0.8144080329298082,FUN_039935-T1,Peve_00036234,Pocillopora_meandrina_HIv1___RNAseq.g7328.t1,three_way,60.9255,FUN_039935-T1,Q3TLH4,,,,,29.5,451.0,5.8e-24,116.3,sp|Q3TLH4|PRC2C_MOUSE Protein PRRC2C OS=Mus musculus OX=10090 GN=Prrc2c PE=1 SV=3,,,,,,
OG_05094,0.8130697741084091,FUN_023341-T1,Peve_00023294,Pocillopora_meandrina_HIv1___RNAseq.g17422.t2,three_way,63.56933333333334,FUN_023341-T1,O15066,KIF3B_HUMAN,,"Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]",Homo sapiens (Human),28.9,557.0,1.3000000000000002e-44,183.7,sp|O15066|KIF3B_HUMAN Kinesin-like protein KIF3B OS=Homo sapiens OX=9606 GN=KIF3B PE=1 SV=1,GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0005929; GO:0007018; GO:0007052; GO:0007100; GO:0007368; GO:0008017; GO:0008089; GO:0008574; GO:0015630; GO:0016020; GO:0016192; GO:0016887; GO:0016939; GO:0030425; GO:0030496; GO:0031267; GO:0032467; GO:0032839; GO:0036372; GO:0042073; GO:0043197; GO:0060271; GO:0070062; GO:0072383; GO:0090307; GO:0097542; GO:0098971; GO:0098978; GO:0120170; GO:1904115,anterograde axonal transport [GO:0008089]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; opsin transport [GO:0036372]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; vesicle-mediated transport [GO:0016192],axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; small GTPase binding [GO:0031267],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_00699,0.8120680033806154,FUN_002429-T1,Peve_00034034,Pocillopora_meandrina_HIv1___RNAseq.g14851.t1,three_way,83.17716666666666,FUN_002429-T1,P09215,KPCD_RAT,,Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],Rattus norvegicus (Rat),51.9,696.0,1.1e-207,724.5,sp|P09215|KPCD_RAT Protein kinase C delta type OS=Rattus norvegicus OX=10116 GN=Prkcd PE=1 SV=1,GO:0001666; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006915; GO:0006974; GO:0006979; GO:0008047; GO:0008270; GO:0009410; GO:0009612; GO:0009749; GO:0016020; GO:0016064; GO:0016363; GO:0018105; GO:0019899; GO:0019901; GO:0023021; GO:0030837; GO:0032869; GO:0032930; GO:0032956; GO:0032963; GO:0034351; GO:0034599; GO:0034644; GO:0035556; GO:0036019; GO:0042100; GO:0042119; GO:0042149; GO:0042307; GO:0042325; GO:0042542; GO:0042742; GO:0043065; GO:0043200; GO:0043409; GO:0043410; GO:0043560; GO:0043687; GO:0045471; GO:0046326; GO:0046627; GO:0048471; GO:0050728; GO:0051490; GO:0060326; GO:0070301; GO:0070779; GO:0070976; GO:0071447; GO:0090331; GO:0090398; GO:0099524; GO:0106310; GO:0120283; GO:1904385; GO:1904627; GO:2000303; GO:2000304; GO:2000753; GO:2000755; GO:2001235,apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; collagen metabolic process [GO:0032963]; D-aspartate import across plasma membrane [GO:0070779]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of D-glucose import [GO:0046326]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; post-translational protein modification [GO:0043687]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of phosphorylation [GO:0042325]; response to amino acid [GO:0043200]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to phorbol 13-acetate 12-myristate [GO:1904627]; response to xenobiotic stimulus [GO:0009410]; termination of signal transduction [GO:0023021],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524],"ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; protein tyrosine kinase activity [GO:0004713]; TIR domain binding [GO:0070976]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003824; GO:0005634; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005829; GO:0005886; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0048870; GO:0055085; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; cytosol; plasma membrane; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; cell motility; transmembrane transport; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04256,0.8092158678010763,FUN_017787-T1,Peve_00040530,Pocillopora_meandrina_HIv1___RNAseq.g9522.t1,three_way,41.8165,FUN_017787-T1,Q5VT06,CE350_HUMAN,,Centrosome-associated protein 350 (Cep350) (Centrosome-associated protein of 350 kDa),Homo sapiens (Human),39.4,66.0,1.1e-06,56.2,sp|Q5VT06|CE350_HUMAN Centrosome-associated protein 350 OS=Homo sapiens OX=9606 GN=CEP350 PE=1 SV=1,GO:0005654; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0008017; GO:0016020; GO:0034453; GO:0036064; GO:0043231; GO:0071539; GO:1905515,microtubule anchoring [GO:0034453]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; spindle [GO:0005819],microtubule binding [GO:0008017],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0008092; GO:0043226; GO:0044782,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; cytoskeletal protein binding; organelle; cilium organization
OG_01887,0.8073135633398306,FUN_007866-T1,Peve_00044451,Pocillopora_meandrina_HIv1___RNAseq.g18302.t1,three_way,87.58333333333333,FUN_007866-T1,Q07352,TISB_HUMAN,,"mRNA decay activator protein ZFP36L1 (Butyrate response factor 1) (EGF-response factor 1) (ERF-1) (TPA-induced sequence 11b) (Zinc finger protein 36, C3H1 type-like 1) (ZFP36-like 1)",Homo sapiens (Human),93.3,30.0,2.2e-11,71.2,sp|Q07352|TISB_HUMAN mRNA decay activator protein ZFP36L1 OS=Homo sapiens OX=9606 GN=ZFP36L1 PE=1 SV=1,GO:0000165; GO:0000288; GO:0000932; GO:0001570; GO:0003342; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006417; GO:0006915; GO:0007507; GO:0008270; GO:0008283; GO:0009611; GO:0010468; GO:0010837; GO:0021915; GO:0031086; GO:0031440; GO:0032869; GO:0033077; GO:0035264; GO:0035925; GO:0038066; GO:0043488; GO:0043491; GO:0044344; GO:0045577; GO:0045600; GO:0045616; GO:0045647; GO:0045657; GO:0045661; GO:0048382; GO:0051028; GO:0060710; GO:0061158; GO:0070371; GO:0071320; GO:0071356; GO:0071364; GO:0071375; GO:0071385; GO:0071456; GO:0071472; GO:0071560; GO:0071889; GO:0072091; GO:0097403; GO:1900153; GO:1901991; GO:1902172; GO:1904582; GO:1990904,"3'-UTR-mediated mRNA destabilization [GO:0061158]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to raffinose [GO:0097403]; cellular response to salt stress [GO:0071472]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; chorio-allantoic fusion [GO:0060710]; ERK1 and ERK2 cascade [GO:0070371]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; mesendoderm development [GO:0048382]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism growth [GO:0035264]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; neural tube development [GO:0021915]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; p38MAPK cascade [GO:0038066]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; proepicardium development [GO:0003342]; regulation of B cell differentiation [GO:0045577]; regulation of gene expression [GO:0010468]; regulation of keratinocyte apoptotic process [GO:1902172]; regulation of keratinocyte differentiation [GO:0045616]; regulation of keratinocyte proliferation [GO:0010837]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA stability [GO:0043488]; regulation of myoblast differentiation [GO:0045661]; regulation of stem cell proliferation [GO:0072091]; regulation of translation [GO:0006417]; response to wounding [GO:0009611]; T cell differentiation in thymus [GO:0033077]; vasculogenesis [GO:0001570]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904],14-3-3 protein binding [GO:0071889]; DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0005634; GO:0005829; GO:0007155; GO:0012501; GO:0016071; GO:0030154; GO:0043226; GO:0048856,immune system process; DNA binding; RNA binding; nucleus; cytosol; cell adhesion; programmed cell death; mRNA metabolic process; cell differentiation; organelle; anatomical structure development
OG_00141,0.8064559895083792,FUN_000580-T1,Peve_00034764,Pocillopora_meandrina_HIv1___RNAseq.g29301.t1,three_way,44.83516666666667,FUN_000580-T1,Q7KM13,,,,,30.5,164.0,6.6e-08,60.5,sp|Q7KM13|HEY_DROME Hairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,,,,,,
OG_09596,0.8040552525320274,FUN_041743-T1,Peve_00002188,Pocillopora_meandrina_HIv1___RNAseq.g15788.t1,three_way,64.87933333333334,,,,,,,,,,,,,,,,,
OG_04601,0.7968626573538792,FUN_022288-T1,Peve_00003595,Pocillopora_meandrina_HIv1___RNAseq.g4695.t1,three_way,67.76066666666667,FUN_022288-T1,Q9Z340,PARD3_RAT,,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (Atypical PKC-specific-binding protein) (ASBP),Rattus norvegicus (Rat),32.5,805.0,1.7e-76,289.7,sp|Q9Z340|PARD3_RAT Partitioning defective 3 homolog OS=Rattus norvegicus OX=10116 GN=Pard3 PE=1 SV=1,GO:0000226; GO:0002092; GO:0003383; GO:0005546; GO:0005547; GO:0005737; GO:0005819; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0006612; GO:0007155; GO:0008104; GO:0010801; GO:0012505; GO:0016324; GO:0019903; GO:0022011; GO:0030010; GO:0030054; GO:0031643; GO:0032266; GO:0032970; GO:0032991; GO:0033269; GO:0035091; GO:0042802; GO:0043025; GO:0043219; GO:0043220; GO:0043296; GO:0044295; GO:0044319; GO:0045197; GO:0051301; GO:0051642; GO:0051660; GO:0060341; GO:0070830; GO:0090162; GO:0120157,"apical constriction [GO:0003383]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome localization [GO:0051642]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; positive regulation of receptor internalization [GO:0002092]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; regulation of actin filament-based process [GO:0032970]; regulation of cellular localization [GO:0060341]; wound healing, spreading of cells [GO:0044319]",adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; lateral loop [GO:0043219]; neuronal cell body [GO:0043025]; PAR polarity complex [GO:0120157]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819],"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]",GO:0007010; GO:0007155; GO:0007163; GO:0008289; GO:0034330; GO:0043226; GO:0048870,cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; lipid binding; cell junction organization; organelle; cell motility
OG_08292,0.7958550142176425,FUN_036230-T1,Peve_00032846,Pocillopora_meandrina_HIv1___RNAseq.g27551.t1,three_way,66.83933333333333,FUN_036230-T1,Q8TB40,,,,,51.4,319.0,7.7e-96,352.1,sp|Q8TB40|ABHD4_HUMAN (Lyso)-N-acylphosphatidylethanolamine lipase OS=Homo sapiens OX=9606 GN=ABHD4 PE=1 SV=1,,,,,,
OG_01089,0.7948911132668234,FUN_004582-T1,Peve_00012392,Pocillopora_meandrina_HIv1___RNAseq.g6604.t1,three_way,71.762,,,,,,,,,,,,,,,,,
OG_00279,0.7938773741001558,FUN_001064-T1,Peve_00005413,Pocillopora_meandrina_HIv1___RNAseq.g29653.t1,three_way,61.42933333333333,FUN_001064-T1,P22758,,,,,41.1,671.0,1.3e-132,475.3,sp|P22758|TGM1_RABIT Protein-glutamine gamma-glutamyltransferase K OS=Oryctolagus cuniculus OX=9986 GN=TGM1 PE=2 SV=2,,,,,,
OG_01324,0.7932254542639453,FUN_005194-T1,Peve_00001277,Pocillopora_meandrina_HIv1___RNAseq.g15136.t1,three_way,66.81283333333333,,,,,,,,,,,,,,,,,
